14 April 2023
Latham & Watkins Advises on Mirum Pharmaceuticals’ Upsized US$275 Million Convertible Senior Notes Offering
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Greg Rodgers Lead | Latham & Watkins LLP | Partner | capital markets | New York/Los Angeles |
| Shayne Kennedy Lead | Latham & Watkins LLP | Partner | capital markets | Orange County/Bay Area |
| Arash Aminian Baghai Lead | Latham & Watkins LLP | Partner | capital markets | Los Angeles |
| Ryan Gold | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Eric Hanzich | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Andrew Bentz | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Allison (AJ) Blair | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Christopher Hazuka | Latham & Watkins LLP | Partner | intellectual property | Bay Area/San Diego |
| Robert Yeh | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Kristina Funahashi | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Emmanuel Kassim | Latham & Watkins LLP | Associate | tax | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
Stated terms
- Stated value
- USD 275m (US$275 million)
- What the figure measures
- Issue size
- Client
- Mirum Pharmaceuticals, Inc.Issuer
- Counterparties
- initial purchasers (Underwriters)